“As we move forward, I am committed to ensuring that we put our collective efforts towards evaluating the potential of MICVO in a timely fashion,” said Thomas Civik, Interim Chief Executive Officer.

BOSTON--(BUSINESS WIRE)--Pyxis Oncology, an immuno-oncology company focused on developing a new family of antibody-based immunotherapies derived from novel insights into the biology of the tumor ...

Pyxis Controls, specialist in Building Management and Home Automation, today announced the launch of NAViGO, a real breakthrough innovation in home entertainment. 11 November 2009 NAViGO - a never ...